XNAS · BCRX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
$9.84
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BCRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BioCryst Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
1994
Employees
435
Country
US

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.84
Last session
Day high
$9.84
Last session
Day low
$9.84
Last session
Previous close
$9.84
52W high
$10.13
-2.86% from high
52W low
$8.19
85% of range
Market cap
$2.5B
EPS
$-2.9000
Shares out
254.2M
VWAP
$9.84
Last session
Price history computed in-house
1W
-0.95%
SMA 50 $9.31 · above
SMA 200 $9.31 · above
52W position 85%
Veridion warehouse edge

Warehouse intelligence for BCRX.

Veridion Score
75
0: 771: 432: 533: 704: 815: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BCRX insider activity

BioCryst Pharmaceuticals Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BCRX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BCRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BCRX in this window.
Lobbying spend

BCRX lobbying filings, year to date.

Registered lobbying filings matched to BioCryst Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BCRX in this window.
Latest news · BCRX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BCRX.
Options
Sovereign unlock shows live options positioning for BCRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.